Efficacy of preoperative intravenous iron in perioperative blood management after rhinoplastic surgery
Phase 3
- Conditions
- Bleeding during rhinoplasty.00
- Registration Number
- IRCT201701221674N14
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Male or female patients more than 18 years of age; no history of drug use; and willingness to cooperate in this study are enrolled. Exclusion criteria: patients with known allergy to the study drug; history of thromboembolic episodes; iron overload; hematologic diseases; hepatic and renal dysfunction; preoperative autologous blood donation and lack of signed informed consent will be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin concentration. Timepoint: Pre operatio and post operation. Method of measurement: Questionnaire Lab. (g/dL).
- Secondary Outcome Measures
Name Time Method Transfused blood products. Timepoint: perioperatively. Method of measurement: number of units.;Hemoglobin. Timepoint: Post operative. Method of measurement: g/dL.;Blood Pressure. Timepoint: During administration. Method of measurement: Blood pressure monitoring.